Ongoing Phase I clinical trial demonstrates successful re-treatment with CAR T cell therapy

A network of molecules and atoms of glass and crystals constitute a single system. 3D illustration

Researchers from the University of Pennsylvania’s Abramson Cancer Center presented preliminary results of an ongoing Phase I clinical trial demonstrating successful re-treatment with CAR T cell therapy for patients whose cancers relapsed after previous CAR T therapy at the 2022 American Society of Hematology Annual Meeting.

‘Quordle’ today: Here are the answers and hints for December 12

Previous article

WhatsApp is working on ‘view once’ messages

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News